CTCL drugs
Nov 11, 2022
How Will the Emerging Therapies for Cutaneous T-cell Lymphoma Reshuffle its Treatment Landscape
Cutaneous T-cell lymphoma (CTCLs) characterized by cutaneous infiltration of malignant monoclonal T-lymphocytes is a rare lymphoma affecting around 6.4 cases per million individuals every year. The total incident population of Cutaneous T-cell lymphoma in the 7MM was around 7.5K in 2021, with the US accounting for ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
